Vaxart, Inc.
VXRT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $72,413 | $39,730 | $20,876 | $15,185 |
| % Growth | 82.3% | 90.3% | 37.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $72,413 | $39,730 | $20,876 | $15,185 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $75,947 | $49,735 | $30,744 | $22,654 |
| G&A Expenses | $4,277 | $4,598 | $5,067 | $4,023 |
| SG&A Expenses | $4,277 | $4,598 | $5,067 | $4,023 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $80,224 | $54,333 | $35,811 | $26,677 |
| Operating Income | -$7,811 | -$14,603 | -$14,935 | -$11,492 |
| % Margin | -10.8% | -36.8% | -71.5% | -75.7% |
| Other Income/Exp. Net | -$313 | -$363 | -$561 | -$317 |
| Pre-Tax Income | -$8,124 | -$14,966 | -$15,496 | -$11,809 |
| Tax Expense | $17 | $20 | $95 | $176 |
| Net Income | -$8,141 | -$14,986 | -$15,591 | -$11,985 |
| % Margin | -11.2% | -37.7% | -74.7% | -78.9% |
| EPS | -0.04 | -0.07 | -0.068 | -0.053 |
| % Growth | 42.9% | -2.3% | -30% | – |
| EPS Diluted | -0.04 | -0.07 | -0.068 | -0.053 |
| Weighted Avg Shares Out | 228,926 | 228,368 | 227,924 | 227,774 |
| Weighted Avg Shares Out Dil | 228,926 | 228,368 | 227,924 | 227,774 |
| Supplemental Information | – | – | – | – |
| Interest Income | $302 | $310 | $437 | $602 |
| Interest Expense | $608 | $672 | $997 | $924 |
| Depreciation & Amortization | $2,080 | $2,197 | $2,247 | $2,236 |
| EBITDA | -$5,436 | -$12,097 | -$12,252 | -$8,649 |
| % Margin | -7.5% | -30.4% | -58.7% | -57% |